Journal of the Pancreas has got its own reputation among all peer-reviewed journals on Autoimmune pancreatitis by publishing the high quality articles and editorials which provide the information about most advanced research findings on Autoimmune pancreatitis. Autoimmune pancreatitis (AIP) is a newly discovered type of chronic pancreatitis that can be difficult to distinguish from pancreatic carcinoma. Autoimmune pancreatitis (AIP) is found to responds to treatment with corticosteroids, especially prednisone. Nowadays it is regarded as a form of hyper-IgG4 disease. There are two categories of AIP: Types 1 and Type 2 each with different clinical profiles. Type 1 AIP patients tended to be older and have a high relapse rate, but patients with Type 2 AIP do not experience relapse and tend to be younger. AIP does not affect long-term survival. Journal of the Pancreas is strongly supported by efficient editorial board members and expert reviewers of OMICS Publishing Group who are actively involved in qualitative review process through which advanced and explanatory articles get published. OMICS Publishing Group the publisher of Journal of Forensic Biomechanics is successfully managing more than 350 peer reviewed journals and organizing around 100 International conferences around the globe annually.

Share this page